These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18779052)

  • 61. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.
    Chibo D; Druce J; Sasadeusz J; Birch C
    Antiviral Res; 2004 Feb; 61(2):83-91. PubMed ID: 14670581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture.
    Donahue DA; Sloan RD; Kuhl BD; Bar-Magen T; Schader SM; Wainberg MA
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1047-54. PubMed ID: 20038621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spectrum of antiviral activity of o-(acetoxyphenyl)hept-2-ynyl sulphide (APHS).
    Pereira CF; Rutten K; Stránská R; Huigen MC; Aerts PC; de Groot RJ; Egberink HF; Schuurman R; Nottet HS
    Int J Antimicrob Agents; 2005 May; 25(5):419-26. PubMed ID: 15848298
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
    Schalkwijk HH; Shewakramani NR; Das K; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2024 May; 68(5):e0011024. PubMed ID: 38619252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye.
    Chen Y; Kalia YN
    Int J Pharm; 2018 Jan; 536(1):292-300. PubMed ID: 29198810
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells.
    Baskin H; Yazici Z; Baskin Y; Olgun N; Ozkul A; Bahar IH
    New Microbiol; 2005 Jul; 28(3):205-13. PubMed ID: 16240692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-1 reverse transcriptase and antiviral drug resistance. Part 1.
    Das K; Arnold E
    Curr Opin Virol; 2013 Apr; 3(2):111-8. PubMed ID: 23602471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
    van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
    J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains.
    Priengprom T; Ekalaksananan T; Kongyingyoes B; Suebsasana S; Aromdee C; Pientong C
    BMC Complement Altern Med; 2015 Mar; 15():56. PubMed ID: 25879785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.
    Xu HT; Colby-Germinario SP; Asahchop EL; Oliveira M; McCallum M; Schader SM; Han Y; Quan Y; Sarafianos SG; Wainberg MA
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3100-9. PubMed ID: 23612196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.
    McMahon MA; Parsons TL; Shen L; Siliciano JD; Siliciano RF
    J Virol; 2011 May; 85(9):4618-22. PubMed ID: 21325417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses.
    Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F
    Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2.
    Vilhelmova-Ilieva N; Jacquet R; Quideau S; Galabov AS
    Antiviral Res; 2014 Oct; 110():104-14. PubMed ID: 25111906
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of the antiviral activity against caprine herpesvirus type 1 of Acyclovir in association with Mizoribine.
    Camero M; Buonavoglia D; Lucente MS; Losurdo M; Crescenzo G; Trerotoli P; Casalino E; Martella V; Elia G; Tempesta M
    Res Vet Sci; 2017 Apr; 111():120-123. PubMed ID: 28235707
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
    Thompson KD
    Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.